First Graphene offers a high-upside graphene commercialization option, but subscale revenue, AUD 1.659 million cash burn and a probability-weighted USD 0.0290 target make the stock highly speculative.
Overview
First Graphene Limited is an early-stage advanced-materials supplier transitioning from R&D toward commercial-scale graphene production. Revenue comes from PureGRAPH product sales, licensing and functionalized additives, custom engineering projects and government-backed grants. Its Henderson, Western Australia plant provides 100 tonnes per annum of capacity, while UK R&D and the MITO acquisition expand technical and North American reach. **The core competitive proposition is consistent commercial-volume graphene produced through a lower-cost electrochemical exfoliation process**, supported by AICIS and European REACH registrations and pending US EPA approval. Commercial evidence is improving, including a 600-tonne Breedon cement run and approximately 10,000 FP McCann roof tiles, but conversion into recurring orders remains unproven. Q3 FY2026 combined income was only AUD 130,000, including AUD 92,000 of product sales, while nine-month operating cash outflow was AUD 1.659 million. The stock traded at AUD 0.060, or approximately USD 0.0396, implying over 93.0x LTM sales and a 6.1x–6.5x price-to-book multiple. The probability-weighted five-year target is USD 0.0290 versus USD 0.0396 today. Near-term catalysts are US EPA registration, Breedon and FP McCann commercial orders, quarterly receipts above AUD 250,000 and MITO-led defense or aerospace contracts.